financetom
Business
financetom
/
Business
/
Tata AIA Life posts 44% growth in new business premium to Rs 1193 cr in Q3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata AIA Life posts 44% growth in new business premium to Rs 1193 cr in Q3
Feb 24, 2022 11:13 AM

Tata AIA Life Insurance Co on February 24 said its individual weighted new business premium (IWNBP) jumped 44 percent to Rs 1,193 crore during the third quarter of fiscal 2021-22. The private life insurer had stood at Rs 831 crore in the year-ago period.

Share Market Live

NSE

For the nine-month period ended December 2021, it registered a growth of 32 percent with an IWNBP income of Rs 2,786 crore, compared with Rs 2,110 crore for the same period of the previous financial year, according to a statement. Total premium income for Q3 FY22 stood at Rs 3,652 crore, compared with Rs 2,766 crore, a growth of 32 percent.

The total premium income in April-December 2021 increased to Rs 8,907 crore, compared with Rs 7,035 crore in the year-ago period. Its retail protection business grew 89 percent in the October-December 2021 period. The retail sum assured for Q3 FY22 stood at Rs 102,520 crore, a growth of 148 percent over the same period last year and a market share of 25.4 percent against 13.1 percent, the statement said.

For the third quarter of FY22, the company registered a 13th month persistency ratio of 86.68 percent, an increase from 85.38 percent for the same period of the previous financial year. As of December 2021, its total assets under management (AUM) stood at Rs 55,492 crore.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,389,756, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,389,756, According to a Recent SEC Filing
Jul 11, 2025
04:42 PM EDT, 07/11/2025 (MT Newswires) -- Hunter C Smith, Chief Financial Officer, on July 09, 2025, sold 42,120 shares in Rhythm Pharmaceuticals ( RYTM ) for $3,389,756. Following the Form 4 filing with the SEC, Smith has control over a total of 116,915 common shares of the company, with 116,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465925067431/xslF345X05/tm2520691-4_4seq1.xml ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Rhythm Pharmaceuticals Insider Sold Shares Worth $308,217, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $308,217, According to a Recent SEC Filing
Jul 11, 2025
04:42 PM EDT, 07/11/2025 (MT Newswires) -- Christopher Paul German, Corporate Controller & Chief Accounting Officer, on July 09, 2025, sold 3,817 shares in Rhythm Pharmaceuticals ( RYTM ) for $308,217. Following the Form 4 filing with the SEC, German has control over a total of 922 common shares of the company, with 922 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465925067428/xslF345X05/tm2520691-2_4seq1.xml...
Rhythm Pharmaceuticals Insider Sold Shares Worth $619,851, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $619,851, According to a Recent SEC Filing
Jul 11, 2025
04:42 PM EDT, 07/11/2025 (MT Newswires) -- Joseph Shulman, Chief Technical Officer, on July 09, 2025, sold 7,969 shares in Rhythm Pharmaceuticals ( RYTM ) for $619,851. Following the Form 4 filing with the SEC, Shulman has control over a total of 8,509 common shares of the company, with 8,509 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465925067430/xslF345X05/tm2520691-3_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved